COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Time to Hip Fracture Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03749122
Recruitment Status : Completed
First Posted : November 21, 2018
Last Update Posted : November 26, 2018
Information provided by (Responsible Party):
Bengt Nellgard, Sahlgrenska University Hospital, Sweden

Brief Summary:
The purpose of the study is to evaluate how time from hospital admission to start of surgery influence mortality in patients with acute hip fracture. Data on patients with hip fracture surgery will be collected from the hospital's registration system and will be analyzed regarding age, gender, American Society of Anesthesiologists (ASA) Physical Status Classification, type of surgery and time from admission to surgery along with data on mortality.

Condition or disease Intervention/treatment
Hip Fractures Mortality Surgery Procedure: Waiting time for hip fracture surgery

Layout table for study information
Study Type : Observational
Actual Enrollment : 10000 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Preoperative Waiting Time to Surgery Related to Mortality in Hip Fracture Patients
Actual Study Start Date : January 1, 2006
Actual Primary Completion Date : December 31, 2016
Actual Study Completion Date : December 31, 2016

Resource links provided by the National Library of Medicine

Intervention Details:
  • Procedure: Waiting time for hip fracture surgery
    Time from hospital admission to start of hip fracture surgery

Primary Outcome Measures :
  1. Mortality [ Time Frame: 30 days ]
    Date of Death captured through Swedish Taxation Authority within 30 days

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with acute hip fracture

Inclusion Criteria: undergoing

  • hip fracture surgery between 2007-2016.
  • Over 60 years of age.

Exclusion Criteria:

  • Pathological fracture.
  • In-hospital falls.
  • Diagnostic delay.
Layout table for additonal information
Responsible Party: Bengt Nellgard, Associate professor, Sahlgrenska University Hospital, Sweden Identifier: NCT03749122    
Other Study ID Numbers: 331-16
First Posted: November 21, 2018    Key Record Dates
Last Update Posted: November 26, 2018
Last Verified: November 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Fractures, Bone
Hip Fractures
Wounds and Injuries
Femoral Fractures
Hip Injuries
Leg Injuries